posted on 2025-04-08, 03:32authored byJean Addington, Lu Liu, Amy Braun, Andrea Auther, Monica E Calkins, Barbara A Cornblatt, Cheryl M Corcoran, Paolo Fusar-Poli, Melissa J Kerr, Catalina V Mourgues-Codern, Angela R Nunez, Dominic Oliver, Gregory P Strauss, Barbara C Walsh, Luis K Alameda, Celso Arango, Nicholas JK Breitborde, Matthew R Broome, Kristin S Cadenhead, Ricardo E Carrion, Eric Yu Hai Chen, Jimmy Choi, Michael J Coleman, Philippe Conus, Covadonga M Diaz-Caneja, Dominic Dwyer, Lauren M Ellman, Masoomeh Faghankhani, Pablo A Gaspar, Carla Gerber, Louise Birkedal Glenthøj, Leslie E Horton, Christy Hui, Grace R Jacobs, Joseph Kambeitz, Lana Kambeitz-Ilankovic, Matcheri S Keshavan, Sung-Wan Kim, Nikolaos Koutsouleris, Jun Soo Kwon, Kerstin Langbein, Kathryn E Lewandowski, Daniel Mamah, Patricia J Marcy, Daniel H Mathalon, Vijay A Mittal, Merete Nordentoft, Godfrey D Pearlson, Nora Penzel, Jesus Perez, Diana O Perkins, Albert R Powers, Jack Rogers, Fred W Sabb, Jason Schiffman, Jai L Shah, Steven M Silverstein, Stefan Smesny, William S Stone, Andrew Thompson, Judy L Thompson, Rachel Upthegrove, Swapna Verma, Jijun Wang, Heather M Wastler, Alana Wickham, Inge Winter-van Rossum, Daniel H Wolf, Sylvain Bouix, Ofer Pasternak, Rene S Kahn, Carrie E Bearden, John M Kane, Patrick D McGorry, Kate Buccilli, Barnaby Nelson, Martha E Shenton, Scott W Woods, Accelerating Medicines Partnership® -Schizophrenia, Alison YungAlison Yung
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.